Annual report
8095.TEDINET S100VBBH
Period2023-12-01 → 2024-11-30
Filed2025-02-27
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 151
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥58.0bn | 2023-12-01 → 2024-11-30 | Cons. | Net sales |
| Revenue | ¥52.0bn | 2022-12-01 → 2023-11-30 | Cons. | Net sales |
| Revenue | ¥49.6bn | 2021-12-01 → 2022-11-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥72.3bn | 2020-12-01 → 2021-11-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥65.3bn | 2019-12-01 → 2020-11-30d | Cons. | Net sales (5-year summary) |
| Operating income | ¥2.8bn | 2023-12-01 → 2024-11-30 | Cons. | Operating income |
| Operating income | ¥1.1bn | 2022-12-01 → 2023-11-30 | Cons. | Operating income |
| Ordinary income | ¥2.8bn | 2023-12-01 → 2024-11-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.4bn | 2022-12-01 → 2023-11-30 | Cons. | Ordinary income |
| Ordinary income | ¥887m | 2021-12-01 → 2022-11-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.4bn | 2020-12-01 → 2021-11-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.0bn | 2019-12-01 → 2020-11-30d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | −¥1.5bn | 2023-12-01 → 2024-11-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.6bn | 2022-12-01 → 2023-11-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥2.5bn | 2023-12-01 → 2024-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.2bn | 2022-12-01 → 2023-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥580m | 2021-12-01 → 2022-11-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.7bn | 2020-12-01 → 2021-11-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.0bn | 2019-12-01 → 2020-11-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | −¥2.5bn | 2023-12-01 → 2024-11-30 | Cons. | Profit loss |
| Net income | ¥1.2bn | 2022-12-01 → 2023-11-30 | Cons. | Profit loss |
| Total assets | ¥64.6bn | at 2024-11-30 | Cons. | Assets |
| Total assets | ¥67.3bn | at 2023-11-30 | Cons. | Assets |
| Total assets | ¥63.6bn | at 2022-11-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥63.6bn | at 2021-11-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥54.3bn | at 2020-11-30d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥39.3bn | at 2024-11-30 | Cons. | Liabilities |
| Total liabilities | ¥38.7bn | at 2023-11-30 | Cons. | Liabilities |
| Net assets / equity | ¥25.3bn | at 2024-11-30 | Cons. | Net assets |
| Net assets / equity | ¥28.6bn | at 2023-11-30 | Cons. | Net assets |
| Net assets / equity | ¥27.1bn | at 2022-11-30d | Cons. | Net assets |
| Net assets / equity | ¥27.0bn | at 2021-11-30d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥21.7bn | at 2020-11-30d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥6.1bn | at 2024-11-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.9bn | at 2023-11-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥6.0bn | at 2024-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.8bn | at 2023-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.8bn | at 2022-11-30d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.8bn | at 2021-11-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥7.4bn | at 2020-11-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥4.8bn | 2023-12-01 → 2024-11-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.6bn | 2022-12-01 → 2023-11-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥742m | 2021-12-01 → 2022-11-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.3bn | 2020-12-01 → 2021-11-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥4.1bn | 2019-12-01 → 2020-11-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥2.9bn | 2023-12-01 → 2024-11-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.8bn | 2022-12-01 → 2023-11-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.2bn | 2021-12-01 → 2022-11-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥4.4bn | 2020-12-01 → 2021-11-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥8.3bn | 2019-12-01 → 2020-11-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥2.7bn | 2023-12-01 → 2024-11-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.1bn | 2022-12-01 → 2023-11-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.1bn | 2021-12-01 → 2022-11-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥6.4bn | 2020-12-01 → 2021-11-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥6.8bn | 2019-12-01 → 2020-11-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-63.18 | 2023-12-01 → 2024-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥29.47 | 2022-12-01 → 2023-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥14.56 | 2021-12-01 → 2022-11-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥46.86 | 2020-12-01 → 2021-11-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥60.33 | 2019-12-01 → 2020-11-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥46.63 | 2020-12-01 → 2021-11-30d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥625.15 | at 2024-11-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥719.53 | at 2023-11-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥685.24 | at 2022-11-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥677.09 | at 2021-11-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥656.54 | at 2020-11-30d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 39.0% | at 2024-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.3% | at 2023-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.5% | at 2022-11-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.5% | at 2021-11-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.9% | at 2020-11-30d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | -9.4% | 2023-12-01 → 2024-11-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 4.2% | 2022-12-01 → 2023-11-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 2.1% | 2021-12-01 → 2022-11-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.1% | 2020-12-01 → 2021-11-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.4% | 2019-12-01 → 2020-11-30d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,420 | at 2024-11-30 | Cons. | Number of employees |
| Employees | 1,404 | at 2023-11-30 | Cons. | Number of employees |
| Employees | 1,383 | at 2022-11-30d | Cons. | Number of employees |
| Employees | 1,368 | at 2021-11-30d | Cons. | Number of employees |
| Employees | 1,295 | at 2020-11-30d | Cons. | Number of employees |
| Revenue | ¥2.9bn | 2023-12-01 → 2024-11-30 | Standalone | Operating revenue1 |
| Revenue | ¥2.8bn | 2022-12-01 → 2023-11-30 | Standalone | Operating revenue1 |
| Revenue | ¥2.8bn | 2021-12-01 → 2022-11-30d | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥23.0bn | 2020-12-01 → 2021-11-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.3bn | 2020-12-01 → 2021-11-30d | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥47.2bn | 2019-12-01 → 2020-11-30d | Standalone | Net sales (5-year summary) |
| Operating income | ¥85m | 2023-12-01 → 2024-11-30 | Standalone | Operating income |
| Operating income | ¥259m | 2022-12-01 → 2023-11-30 | Standalone | Operating income |
| Ordinary income | −¥29m | 2023-12-01 → 2024-11-30 | Standalone | Ordinary income |
| Ordinary income | ¥210m | 2022-12-01 → 2023-11-30 | Standalone | Ordinary income |
| Ordinary income | ¥290m | 2021-12-01 → 2022-11-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥304m | 2020-12-01 → 2021-11-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥290m | 2019-12-01 → 2020-11-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥215m | 2023-12-01 → 2024-11-30 | Standalone | Income before income taxes |
| Profit before tax | ¥1.0bn | 2022-12-01 → 2023-11-30 | Standalone | Income before income taxes |
| Net income | ¥93m | 2023-12-01 → 2024-11-30 | Standalone | Profit loss |
| Net income | ¥702m | 2022-12-01 → 2023-11-30 | Standalone | Profit loss |
| Net income | ¥831m | 2021-12-01 → 2022-11-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥788m | 2020-12-01 → 2021-11-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥255m | 2019-12-01 → 2020-11-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥31.0bn | at 2024-11-30 | Standalone | Assets |
| Total assets | ¥32.7bn | at 2023-11-30 | Standalone | Assets |
| Total assets | ¥30.1bn | at 2022-11-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥30.2bn | at 2021-11-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥39.3bn | at 2020-11-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥17.3bn | at 2024-11-30 | Standalone | Liabilities |
| Total liabilities | ¥18.0bn | at 2023-11-30 | Standalone | Liabilities |
| Net assets / equity | ¥13.7bn | at 2024-11-30 | Standalone | Net assets |
| Net assets / equity | ¥14.6bn | at 2023-11-30 | Standalone | Net assets |
| Net assets / equity | ¥13.9bn | at 2022-11-30d | Standalone | Net assets |
| Net assets / equity | ¥14.0bn | at 2021-11-30d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥12.9bn | at 2020-11-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥569m | at 2024-11-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥758m | at 2023-11-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥2.32 | 2023-12-01 → 2024-11-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥17.79 | 2022-12-01 → 2023-11-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥20.88 | 2021-12-01 → 2022-11-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥21.27 | 2020-12-01 → 2021-11-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥7.75 | 2019-12-01 → 2020-11-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥21.16 | 2020-12-01 → 2021-11-30d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥18 | 2023-12-01 → 2024-11-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥18 | 2022-12-01 → 2023-11-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥18 | 2021-12-01 → 2022-11-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥18 | 2020-12-01 → 2021-11-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥16 | 2019-12-01 → 2020-11-30d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥340.64 | at 2024-11-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥370.38 | at 2023-11-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥352.82 | at 2022-11-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥350.47 | at 2021-11-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥392.26 | at 2020-11-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 44.2% | at 2024-11-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.8% | at 2023-11-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.2% | at 2022-11-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.3% | at 2021-11-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.9% | at 2020-11-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 0.7% | 2023-12-01 → 2024-11-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 4.9% | 2022-12-01 → 2023-11-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.0% | 2021-12-01 → 2022-11-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.9% | 2020-12-01 → 2021-11-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 1.9% | 2019-12-01 → 2020-11-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 40,982,832 | at 2024-11-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 40,884,504 | at 2023-11-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 40,772,366 | at 2022-11-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 40,630,087 | at 2021-11-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 34,729,839 | at 2020-11-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 95 | at 2024-11-30 | Standalone | Number of employees |
| Employees | 93 | at 2023-11-30 | Standalone | Number of employees |
| Employees | 105 | at 2022-11-30d | Standalone | Number of employees |
| Employees | 109 | at 2021-11-30d | Standalone | Number of employees |
| Employees | 323 | at 2020-11-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 84
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2023-12-01 → 2024-11-30 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2024-11-30 | 11 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-12-01 → 2024-11-30 | ¥46m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-12-01 → 2024-11-30 | ¥38m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-12-01 → 2024-11-30 | ¥8m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-12-01 → 2024-11-30 | −¥137m |
| Reconciling Itemsreconciling | depreciation | 2023-12-01 → 2024-11-30 | ¥427m |
| Reconciling Itemsreconciling | revenue | 2023-12-01 → 2024-11-30 | −¥1.4bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-12-01 → 2024-11-30 | −¥1.4bn |
| Reconciling Itemsreconciling | segment profit | 2023-12-01 → 2024-11-30 | −¥61m |
| Fine Chemicalsreportable segment | depreciation | 2023-12-01 → 2024-11-30 | ¥1.0bn |
| Fine Chemicalsreportable segment | employees | at 2024-11-30 | 546 pure |
| Fine Chemicalsreportable segment | revenue | 2023-12-01 → 2024-11-30 | ¥22.0bn |
| Fine Chemicalsreportable segment | revenue external | 2023-12-01 → 2024-11-30 | ¥21.1bn |
| Fine Chemicalsreportable segment | revenue intersegment | 2023-12-01 → 2024-11-30 | ¥912m |
| Fine Chemicalsreportable segment | segment profit | 2023-12-01 → 2024-11-30 | ¥243m |
| Health And Beauty Care Foodreportable segment | depreciation | 2023-12-01 → 2024-11-30 | ¥49m |
| Health And Beauty Care Foodreportable segment | employees | at 2024-11-30 | 229 pure |
| Health And Beauty Care Foodreportable segment | revenue | 2023-12-01 → 2024-11-30 | ¥15.3bn |
| Health And Beauty Care Foodreportable segment | revenue external | 2023-12-01 → 2024-11-30 | ¥15.2bn |
| Health And Beauty Care Foodreportable segment | revenue intersegment | 2023-12-01 → 2024-11-30 | ¥94m |
| Health And Beauty Care Foodreportable segment | segment profit | 2023-12-01 → 2024-11-30 | ¥742m |
| Industrial Chemicalsreportable segment | depreciation | 2023-12-01 → 2024-11-30 | ¥323m |
| Industrial Chemicalsreportable segment | employees | at 2024-11-30 | 325 pure |
| Industrial Chemicalsreportable segment | revenue | 2023-12-01 → 2024-11-30 | ¥10.3bn |
| Industrial Chemicalsreportable segment | revenue external | 2023-12-01 → 2024-11-30 | ¥10.2bn |
| Industrial Chemicalsreportable segment | revenue intersegment | 2023-12-01 → 2024-11-30 | ¥70m |
| Industrial Chemicalsreportable segment | segment profit | 2023-12-01 → 2024-11-30 | ¥713m |
| Medicalreportable segment | depreciation | 2023-12-01 → 2024-11-30 | ¥211m |
| Medicalreportable segment | employees | at 2024-11-30 | 205 pure |
| Medicalreportable segment | revenue | 2023-12-01 → 2024-11-30 | ¥11.8bn |
| Medicalreportable segment | revenue external | 2023-12-01 → 2024-11-30 | ¥11.5bn |
| Medicalreportable segment | revenue intersegment | 2023-12-01 → 2024-11-30 | ¥316m |
| Medicalreportable segment | segment profit | 2023-12-01 → 2024-11-30 | ¥1.3bn |
| —segment total | depreciation | 2023-12-01 → 2024-11-30 | ¥1.6bn |
| —segment total | employees | at 2024-11-30 | 1305 pure |
| —segment total | revenue | 2023-12-01 → 2024-11-30 | ¥59.3bn |
| —segment total | revenue external | 2023-12-01 → 2024-11-30 | ¥58.0bn |
| —segment total | revenue intersegment | 2023-12-01 → 2024-11-30 | ¥1.4bn |
| —segment total | segment profit | 2023-12-01 → 2024-11-30 | ¥3.0bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-12-01 → 2024-11-30 | ¥1.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-12-01 → 2024-11-30 | ¥59.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-12-01 → 2024-11-30 | ¥58.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-12-01 → 2024-11-30 | ¥1.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-12-01 → 2024-11-30 | ¥2.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2022-12-01 → 2023-11-30 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-12-01 → 2023-11-30 | ¥19m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-12-01 → 2023-11-30 | ¥17m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-12-01 → 2023-11-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-12-01 → 2023-11-30 | −¥104m |
| Reconciling Itemsreconciling | depreciation | 2022-12-01 → 2023-11-30 | ¥444m |
| Reconciling Itemsreconciling | revenue | 2022-12-01 → 2023-11-30 | −¥1.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-12-01 → 2023-11-30 | −¥1.5bn |
| Reconciling Itemsreconciling | segment profit | 2022-12-01 → 2023-11-30 | ¥99m |
| Fine Chemicalsreportable segment | depreciation | 2022-12-01 → 2023-11-30 | ¥874m |
| Fine Chemicalsreportable segment | revenue | 2022-12-01 → 2023-11-30 | ¥20.9bn |
| Fine Chemicalsreportable segment | revenue external | 2022-12-01 → 2023-11-30 | ¥19.9bn |
| Fine Chemicalsreportable segment | revenue intersegment | 2022-12-01 → 2023-11-30 | ¥1.0bn |
| Fine Chemicalsreportable segment | segment profit | 2022-12-01 → 2023-11-30 | ¥214m |
| Health And Beauty Care Foodreportable segment | depreciation | 2022-12-01 → 2023-11-30 | ¥69m |
| Health And Beauty Care Foodreportable segment | revenue | 2022-12-01 → 2023-11-30 | ¥14.1bn |
| Health And Beauty Care Foodreportable segment | revenue external | 2022-12-01 → 2023-11-30 | ¥14.1bn |
| Health And Beauty Care Foodreportable segment | revenue intersegment | 2022-12-01 → 2023-11-30 | ¥84m |
| Health And Beauty Care Foodreportable segment | segment profit | 2022-12-01 → 2023-11-30 | ¥325m |
| Industrial Chemicalsreportable segment | depreciation | 2022-12-01 → 2023-11-30 | ¥336m |
| Industrial Chemicalsreportable segment | revenue | 2022-12-01 → 2023-11-30 | ¥8.7bn |
| Industrial Chemicalsreportable segment | revenue external | 2022-12-01 → 2023-11-30 | ¥8.6bn |
| Industrial Chemicalsreportable segment | revenue intersegment | 2022-12-01 → 2023-11-30 | ¥66m |
| Industrial Chemicalsreportable segment | segment profit | 2022-12-01 → 2023-11-30 | ¥74m |
| Medicalreportable segment | depreciation | 2022-12-01 → 2023-11-30 | ¥168m |
| Medicalreportable segment | revenue | 2022-12-01 → 2023-11-30 | ¥9.8bn |
| Medicalreportable segment | revenue external | 2022-12-01 → 2023-11-30 | ¥9.5bn |
| Medicalreportable segment | revenue intersegment | 2022-12-01 → 2023-11-30 | ¥362m |
| Medicalreportable segment | segment profit | 2022-12-01 → 2023-11-30 | ¥520m |
| —segment total | depreciation | 2022-12-01 → 2023-11-30 | ¥1.4bn |
| —segment total | revenue | 2022-12-01 → 2023-11-30 | ¥53.5bn |
| —segment total | revenue external | 2022-12-01 → 2023-11-30 | ¥52.0bn |
| —segment total | revenue intersegment | 2022-12-01 → 2023-11-30 | ¥1.5bn |
| —segment total | segment profit | 2022-12-01 → 2023-11-30 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-12-01 → 2023-11-30 | ¥1.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-12-01 → 2023-11-30 | ¥53.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-12-01 → 2023-11-30 | ¥52.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-12-01 → 2023-11-30 | ¥1.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-12-01 → 2023-11-30 | ¥1.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,924
| Item | Context | Value | Unit |
|---|---|---|---|
| Current liabilities | Prior1YearInstant | 29981620000 | JPY |
| Current liabilities | CurrentYearInstant | 31903357000 | JPY |
| Long term loans payable | Prior1YearInstant | 4493332000 | JPY |
| Long term loans payable | CurrentYearInstant | 3445348000 | JPY |
| Lease obligations ncl | Prior1YearInstant | 146283000 | JPY |
| Lease obligations ncl | CurrentYearInstant | 86179000 | JPY |
| Deferred tax liabilities | Prior1YearInstant | 965738000 | JPY |
| Deferred tax liabilities | CurrentYearInstant | 909483000 | JPY |
| Provision for share based payments ncl | Prior1YearInstant | 104846000 | JPY |
| Provision for share based payments ncl | CurrentYearInstant | 105559000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 2553267000 | JPY |
| Net defined benefit liability | CurrentYearInstant | 2403347000 | JPY |
| Other ncl | Prior1YearInstant | 408137000 | JPY |
| Other ncl | CurrentYearInstant | 439858000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 8671606000 | JPY |
| Noncurrent liabilities | CurrentYearInstant | 7389776000 | JPY |
| Liabilities | Prior1YearInstant | 38653227000 | JPY |
| Liabilities | CurrentYearInstant | 39293134000 | JPY |
| Capital stock | Prior1YearInstant | 4581397000 | JPY |
| Capital stock | CurrentYearInstant | 4605094000 | JPY |
| Capital surplus | Prior1YearInstant | 6574102000 | JPY |
| Capital surplus | CurrentYearInstant | 6320723000 | JPY |
| Retained earnings | Prior1YearInstant | 15462238000 | JPY |
| Retained earnings | CurrentYearInstant | 12229650000 | JPY |
| Treasury stock | Prior1YearInstant | -525872000 | JPY |
| Treasury stock | CurrentYearInstant | -255189000 | JPY |
| Shareholders equity | Prior1YearInstant | 26091866000 | JPY |
| Shareholders equity | CurrentYearInstant | 22900278000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 1703144000 | JPY |
| Valuation difference on available for sale securities | CurrentYearInstant | 1388668000 | JPY |
| Deferred gains or losses on hedges | Prior1YearInstant | -94000 | JPY |
| Deferred gains or losses on hedges | CurrentYearInstant | -2689000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 271021000 | JPY |
| Foreign currency translation adjustment | CurrentYearInstant | 319050000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 354348000 | JPY |
| Remeasurements of defined benefit plans | CurrentYearInstant | 560640000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 2328419000 | JPY |
| Valuation and translation adjustments | CurrentYearInstant | 2265670000 | JPY |
| Non controlling interests | Prior1YearInstant | 181236000 | JPY |
| Non controlling interests | CurrentYearInstant | 136182000 | JPY |
| Net assets | Prior1YearInstant | 28601522000 | JPY |
| Net assets | CurrentYearInstant | 25302132000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 67254750000 | JPY |
| Liabilities and net assets | CurrentYearInstant | 64595266000 | JPY |
| Net sales | Prior1YearDuration | 51984426000 | JPY |
| Net sales | CurrentYearDuration | 57993375000 | JPY |
| Cost of sales | Prior1YearDuration | 35666898000 | JPY |
| Cost of sales | CurrentYearDuration | 38623760000 | JPY |
| Gross profit | Prior1YearDuration | 16317527000 | JPY |
| Gross profit | CurrentYearDuration | 19369615000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |